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The RET receptor tyrosine kinase is activated by GDNF and controls outgrowth and invasion of the ureteric bud epithelia in the developing
kidney. In renal epithelial cells and in enteric neuronal precursor cells, activation of RET results in chemotaxis as Ret expressing cells invade the
surrounding GDNF expressing tissue. One potential downstream signaling pathway governing RET mediated chemotaxis may require
phosphatidylinositol 3-kinase (PI3K), which generates PI(3,4,5) triphosphate. The PTEN tumor suppressor gene encodes a protein and lipid
phosphatase that regulates cell growth, apoptosis and many other cellular processes. PTEN helps regulate cellular chemotaxis by antagonizing the
PI3K signaling pathway through dephosphorylation of phosphotidylinositol triphosphates. In this report, we show that PTEN suppresses RET
mediated cell migration and chemotaxis in cell culture assays, that RET activation results in asymmetric localization of inositol triphosphates and
that loss of PTEN affects the pattern of branching morphogenesis in developing mouse kidneys. These data suggest a critical role for the PI3K/
PTEN axis in shaping the pattern of epithelial branches in response to RET activation.
© 2007 Elsevier Inc. All rights reserved.Keywords: PTEN; RET; GDNF; Chemotaxis; Branching morphogenesisIntroduction
The process of epithelial branching morphogenesis occurs
in a variety of developing mammalian tissues, including
mammary gland, the prostate, the lung and the kidney, and
consists of common mechanistic elements (Costantini, 2006;
Lu et al., 2006). Initial outgrowth of an invasive bud is
followed by proliferation and cell migration to generate an
ampullae that bi- or trifurcates to form new buds that will
repeat the process and generate a complex arborized epithelial
network. The pattern of arborization depends on positive
regulation by growth factors and receptors to promote
proliferation and migration and negative regulation to inhibit
excessive budding and bifurcation. How potential positive and
negative signals are integrated to control cell movement,
while retaining the essential character of an invasive epithelia,
remains unclear.⁎ Corresponding author. Fax: +1 734 763 6640.
E-mail address: dressler@umich.edu (G.R. Dressler).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.04.051In the developing kidney, the ureteric bud diverticulum
grows out of the nephric duct and invades a group of adjacent
cells, the metanephric mesenchyme (Dressler, 2006). This
outgrowth is stimulated by glial derived neurotrophic factor
(GDNF), which is expressed in the mesenchyme and activates
the RET receptor tyrosine kinase on the ureteric bud epithelia
through a co-receptor GFRα1 (Costantini and Shakya, 2006).
Loss of RET, GDNF or the co-receptor GFRα1 results in renal
agenesis in mice, due to inhibition of ureteric bud growth and
branching (Cacalano et al., 1998; Moore et al., 1996; Pichel
et al., 1996; Sanchez et al., 1996; Schuchardt et al., 1994). In
cell culture, GDNF is a chemoattractant for RET expressing
epithelial cells (Tang et al., 1998) and is sufficient to promote
ureteric bud outgrowth (Brophy et al., 2001; Sainio et al., 1997).
Similarly, the RET/GDNF pathway is required for migration of
enteric neuron precursor cells into the gut, also through a
chemotactic mechanism (Natarajan et al., 2002).
Chemotaxis in response to extracellular gradients has been
well described in Dictyostelium, in which asymmetry in the
distribution of phosphatidylinositol (3,4,5)-triphosphate, (PI
(3,4,5)P3), can promote directional migration (Funamoto
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Coincident with the activation of phosphatidylinositol 3-
kinase (PI3K) at the leading edges of migrating cells is the
localization of the lipid phosphatase, PTEN, at the trailing
ends. Pten is a tumor suppressor gene whose loss is detected
in a variety of human cancers (Cairns et al., 1998; Li et al.,
1997; Steck et al., 1997). PTEN has a dual specificity protein
phosphatase and lipid phosphatase activity that can depho-
sphorylate PI(3,4,5)P3 (Myers et al., 1997, 1998). Thus,
PTEN antagonizes PI3K activity to suppress protein kinase B
(Akt/PKB) dependent pathways, which can regulate cell
migration, proliferation and apoptosis (Stambolic et al., 1998).
Akt/PKB contains a pleckstrin homology (PH) domain that
mediates binding to PI(3,4,5)P3 to stimulate intracellular
signaling pathways (Lemmon and Ferguson, 2000). Further-
more, the protein phosphatase activity of PTEN includes
dephosphorylation and inactivation of focal adhesion kinase
(FAK), which can modify the interactions between the
extracellular matrix and the cytoskeleton (Tamura et al.,
1998). PTEN can down-regulate integrin-mediated cell
spreading and focal adhesion formation by a phosphatase-
dependent manner, suggesting that PTEN functions in
controlling cell surface interactions in which integrins, focal
adhesion kinase and cell migration are involved (Tamura
et al., 1998). Similarly, the lipid phosphatase Ship1, which
can also dephosphorylate PI(3,4,5)P3, is essential for
neutrophil migration in response to chemotactic gradients
(Nishio et al., 2007).
While the RET/GDNF pathway is essential for early kidney
development, the intracellular mechanism regulating epithelial
cell migration and branching morphogenesis are not entirely
clear. Ligand dependent activation of RET results in the
autophosphorylation of multiple tyrosine residues of which
Y1062 is the most critical for renal development (Wong et al.,
2005). Subsequent recruitment of multiple intracellular
signaling partners, including Shc, Grb2, p85(PI3K), enigma
and Dok-6 (Besset et al., 2000; Crowder et al., 2004;
Degl'Innocenti et al., 2004; Durick et al., 1998), has been
reported. Previously, we have utilized renal epithelial cells that
stably express RET to demonstrate GDNF mediated chemo-
taxis (Tang et al., 1998). In this system, RET activation
increased PI3K activity. Suppression of PI3K by pharmaco-
logical inhibitors inhibited GDNF mediated chemotaxis in
epithelial cells and ureteric bud outgrowth in embryonic organ
cultures (Tang et al., 2002). If the pattern of branching
morphogenesis is shaped by PI3K activation in response to
RET/GDNF, then the lipid phosphatase PTEN may also be
required to down-regulate the signaling responses and fine
tune the pattern during development. To address this question,
we show that PTEN suppresses GDNF/RET mediated cell
migration and chemotaxis in epithelial cell culture. RET
activation results in asymmetric distribution of PI(3,4,5)P3 as
cells approach a gradient of GDNF. Furthermore, loss of
PTEN in the ureteric bud and developing collecting duct
system results in aberrant branching patterns, mislocalization
of glomeruli and lethality. These data indicate an essential role
for PTEN in shaping the pattern of branching morphogenesisin the developing kidney and suggest that PI(3,4,5)P3 is an
important signaling mediator for the GDNF/RET pathway.
Materials and methods
Plasmids
PTEN and PTEN-C124S expression plasmids were kindly provided by J.
Dixon (UCSD, San Diego, CA). PTEN(C124S) is a mutant form in which serine
at 124 is substituted for cysteine and its DNA sequence was confirmed. The
fragments of PTEN-IRES-EGFP or PTEN(C124S)-IRES-EGFP from the
previous constructs were also subcloned into CMV vector (CB6+) to produce
CMV-PTEN-IRES-EGFP and CMV-PTEN(C124S)-IRES-EGFP, respectively,
and used for chemotaxis study. Akt/PKB PH domain-GFP fusion (PH-GFP) was
kindly provided by T. Meyer (Stanford Univ., Palo Alto, CA).
Stable transfection of MDCK cell line
RET-overexpressing MDCK (Ret9) cells were cotransfected with PGK-
Hygro and CMV-PTEN-IRES-EGFP, CMV-PTEN(C124S)-IRES-EGFP or PH-
GFP, respectively, and selected for 10 days with 0.3 mg/ml hygromycin in
Dulbecco's modified Eagles medium (DMEM) supplemented with 10% fetal
bovine serum, 100 U/ml penicillin and 100 μg/ml streptomycin under
humidified 5% CO2/95% air at 37 °C. At least 3 clones from each construct
were obtained and frozen down at −140 °C.
Western blotting
Cells were lysed in PK-lysis buffer (Cai et al., 2002) and protein levels were
quantified by the Bio-Rad colorimetric assay (Bio-Rad, Hercules, CA). SDS/
PAGE sample buffer was added and samples were boiled for 5 min. Samples
were run on a 8% polyacrylamide gel, transferred to PVDF membrane (Perkin-
Elmer, Boston, MA) and blocked with 5% non-fat milk in Tris-buffered saline.
Membranes were immunoblotted with anti-HA antibody (Covance, Richmond,
CA), anti-PTEN antibody (Cell signaling, Beverly, MA) and anti-p-Akt
antibody (Cell signaling, Beverly, MA) in 10 mM Tris, pH 7.5, 100 mM
NaCl, 0.1% Tween 20, 1% non-fat milk. Secondary antibodies conjugated to
horseradish peroxidase were used at a 1:10,000 dilution, and the signal was
visualized by chemiluminescence (Amersham, Buckinghamshire, England). For
quantitation, fluorescent conjugated secondary antibodies and a Li-Cor Odyssey
infrared imager were used to scan the membranes.
Chemoattraction and cell migration assays
For chemoattraction assay, preparation of type I collagen gel and GDNF
bead was described by Tang et al. (1998). RET-PTEN, RET-PTEN(C124S) or
PH-GFP cells were seeded on the surface of the gel at 40,000 cells/well with
DMEM containing 10% fetal bovine serum, 100 U/ml penicillin and 100 μg/ml
streptomycin, 0.3 mg/ml G418, 0.2 mg/ml hygromycin and supplemented with
250 ng/ml GFRα1. Cells around the beads were photographed over time at 24 h
intervals. For cell migration assay, 1×104 cells were plated onto the transwell
filters containing 8 μm pores (Corning, Inc., Corning, NY) with the same media
previously described. GDNF and GFRα1 were added to the bottom chamber or
both the bottom and the top chambers at 100 ng/ml and 250 ng/ml, respectively.
After a 24-h incubation, cells on the filters were fixed with 4% paraformalde-
hyde and stained with DAPI. All experiments were done in triplicate and
averages presented with one standard deviation from the mean.
PTEN tissue specific mutants
The pten floxed allele was obtained from T. Mak and genotyped as
described (Suzuki et al., 2001). The HoxB7-Cre transgene was obtained from
C. Bates and utilized as described previously (Zhao et al., 2004). For organ
cultures, E11.5 kidneys were dissected free and placed on transwell filters in
serum free media. After 48 h of culture, organ rudiments were fixed in methanol
and stained whole with mouse anti-pan-cytokeratin (Sigma) and rabbit anti-
laminin (Sigma).
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Given the potential for PI3K to promote RET mediated
chemotaxis, we asked whether overexpression of the phospha-
tase PTEN could inhibit GDNF/RET mediated cell migration
and chemotaxis in cell culture. If activation of PI3K by RET is
essential for directional mobility, then overexpression of the
phosphatase PTEN should inhibit directional chemotaxis and/or
cell migration in general. PTEN can dephosphorylate PI(3,4,5)
P3 and thus disrupt Akt localization at the cell membrane. Wild-
type PTEN or a phosphatase deficient form PTEN-C124S were
introduced into MDCK cells stably expressing RET (Ret9 cells)
and multiple clones identified by Western blotting (data not
shown). Cells were assayed for their ability to respond to
GDNF/GFRα1 by examining RET and Akt phosphorylation
(Fig. 1A). Immunoprecipitation of HA-tagged RET after GDNF
treatment revealed that in Ret9 cells and all PTEN derivatives,
RET was tyrosine phosphorylated at near equal amounts.
Parental MDCK cells do not express RET and show no P-Tyr
proteins after immunoprecipitation with anti-HA. To assess the
activation of the PI3K pathway, we utilized P-Akt levels as an
indirect readout. Antibodies against P-Akt were used to probe
total lysates before and after GDNF treatment. Ret9 cells show a
strong response as indicated by a doublet recognized by the
anti-P-Akt antibodies. Cells expressing PTEN show an
attenuated response as the higher migrating P-Akt species is
not seen. Ret9 derivatives that express mutant PTEN-C124S
also show high P-Akt levels in response to GDNF, with the
slower migrating form present. These data show that PTEN
expression does not effect RET phosphorylation, but can
suppress the level of P-Akt present, whereas the C124S mutant
PTEN has little affect on P-Akt levels.
Extension of cellular processes and dissociation of cells
from their neighbors are a prerequisite for the chemotacticFig. 1. Ret activation in PTEN expressing cells. (A) Ret9 cells and derivatives expres
of 170 kDa Ret protein after GDNF/GFRα1 addition. Equal amounts of RETwere im
that PTEN expressing cells had attenuated levels of P-Akt as indicated by the absen
(C124S) were grown on plastic in media alone or with GDNF and soluble GFRα1
processes were observed in Ret9 and RET-PTEN(C124S) cells but not in MDCK anresponse mediated by RET activation. To determine if PTEN
suppression can suppress cell scattering and lamellipodia
formation, we utilized the Ret9 cells and the PTEN
expressing derivatives in several assays. In the absence of
RET activation, none of the cells deviated markedly from the
parental MDCK phenotype. Cells on plastic grew as tightly
associated islands. Addition of GDNF and GFRα1 promoted
cell scattering and extension of lamellipodia in Ret9 cells and
in PTEN-C124S mutant cell lines, but less so in cells
expressing PTEN (Fig. 1B). We also plated these cells on thin
collagen gels containing GDNF soaked beads and monitored
cell migration towards the beads over time. As expected,
PTEN expressing cells were unable to migrate directionally
towards a source of GDNF in the bead assay (Fig. 2). The
Ret9 and PTEN-C124S mutant cells had no problem
migrating towards and eventually completely surrounding
the GDNF beads. To quantify chemotaxis more precisely, we
utilized a transwell migration assay. Cells were seeded at high
density onto membranes with 8-micron pores. GDNF was
added to the bottom chamber or to the bottom and the top
chamber and the number of cells migrating through the pores
was counted (Fig. 3). Ret9 cells expressing PTEN had little
chemotactic response to GDNF and were as immobile as
parental MDCK cells that do not express RET. As published
previously, Ret9 cells migrated through the pores when
stimulated with GDNF. More cells were found migrating
through the filter when GDNF was added to the bottom
chamber only, compared to addition of GDNF to the top and
bottom. This is an important distinction that separates random
migration from directional movement. Interestingly, Ret9 cells
expressing the mutant PTEN-C124S showed a small but
significant increase in migration that was evident when
GDNF was added only to the bottom chamber, suggesting
that this mutant may have some dominant negative effects.sing wild-type PTEN or mutant PTEN-C124S all show tyrosine phosphorylation
munoprecipitated with anti-HA. Total lysates were probed with anti-P-Akt. Note
ce of the slower migrating form. (B) MDCK, Ret9, RET-PTEN and RET-PTEN
(GDNF/GFRα1). Dissociation of cell–cell junctions and outgrowth of cellular
d RET-PTEN expressing cells.
Fig. 3. Quantitative transfilter migration assay. Cells were seeded onto the
transwell inserts with 8-micron polycarbonate filters. GDNF and GFRα1 were
added to the bottom chamber only (B) or to both top and bottom chambers (TB).
Controls (C) were cultured in the absence of GDNF/GFRα1. After 24 h, the cells
migrating through the filter were counted. The average numbers of cells per field
are shown with the standard error bars. The Student's t test was performed
between the indicated samples to determine statistical significance.
Fig. 2. PTEN inhibits chemotaxis of Ret9 cells on collagen gels. GDNF beads were placed within thin collagen gels upon which 40,000 cells were seeded and grown
for 4 days. Both the Ret9 and PTEN-C124S derivatives were able to scatter and migrate towards the GDNF beads, eventually surrounding the bead itself. Parental
MDCK cells and PTEN expressing Ret9 cells were unable to dissociate and migrate.
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in Ret9 cells, we utilized a GFP reporter to examine the cellular
localization of activated PI3K in GDNF dependent cell
migration. The pleckstrin homology (PH) domain of AKT
binds to PI(3,4)-diphosphate and PI(3,4,5)-triphosphate and
when fused to GFP can be used to visualize activated PI3-kinase
(Arrieumerlou and Meyer, 2005; Haugh et al., 2000). MDCK
renal epithelial cells expressing RET (Ret9) were transfected
with GFP-AKT(PH) and examined after addition of GDNF/
GFRa1. Activation of RET resulted in GFP localization at the
leading edges of lamellipodia and membrane ruffles (Fig. 4A)
which was not observed in untreated cells (Fig. 4B). The Ret9-
Akt-GFP cells were also plated onto thin collagen gels in which
GDNF containing heparin acrylamide beads were embedded.
Previous experiments had indicated that Ret9 cells dissociated
and migrated towards the source of GDNF (Tang et al., 1998).
Using standard fluorescent microscopy, we examined cells as
they approached the GDNF bead to gauge whether and where
PI3K was active (Figs. 4C–F). As cells extended lamellipodia
towards the beads, GFP fluorescence could be detected at the
leading edges. In fact, GFP was consistently observed on that
side of the cell and on the lamellipodia extending towards the
bead, but not in those extending away from the GDNF bead.
Occasionally, the end of the lamellipodia was bifurcated in two
directions and GFP was seen only on the leading edge facing the
Fig. 4. Localization of active PI3K by AKT-GFP fusion proteins. Ret9 cells were stably transfected with GFP-AKT(PH). (A) Addition of GDNF/GFRα1 stimulated
numerous lamellipodia that show GFP localization at the leading edges (arrows). (B) Untreated Ret9/GFP-AKT cells grow as island with little GFP localization at the
edges. (C–F) Ret9/GFP-AKT cells were plated on collagen gels near GDNF coated beads and examined for GFP localization over time. The position of the GDNF
bead is marked by an asterisk. Note GFP localization along leading edges (C, arrows) but not on the opposite side of the cell (arrowheads). Also, cells show multiple
GFP positive spikes on the side of the cell facing the GDNF bead (D, arrows). GFP localization within a cellular process is asymmetrically localized at the tip (E, E′)
strong at the edge facing the bead (arrow) and weak on the opposite edge (arrowhead). A bifurcated extension (F, F′) again shows strong GFP on the end growing
towards the bead (arrow) but not on the end moving away (arrowhead).
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F). These data suggest that RET signaling and PI3K activation
are responsive to extracellular directional cues and result in
polarized PI3-kinase activation only at the leading edges of the
cell.
RET expression is found along the nephric duct and in the
ureteric bud as it invades the metanephric mesenchyme. As the
ureteric bud branches, RET is restricted to the tips of the buds. The
levels of RET at the tips can be enhanced by GDNF, suggesting
that RET protein expression is autoregulated (Pepicelli et al.,
1997). To test the ability of PTEN to impact early ureteric bud
branching morphogenesis, we generated a tissue specific PTEN
loss-of function kidney by deleting floxed PTEN alleles (Suzuki
et al., 2001) with a HoxB7Cre transgenic driver (Srinivas et al.,
1999; Zhao et al., 2004). The HoxB7Cre transgene is active in the
ureteric bud epithelial and all its derivatives, enabling us to test the
function of PTEN only in the branching epithelial component of
the developing kidney. Mice homozygous for the floxed allele
(ptenL/L) were crossed to ptenL/+ heterozygous mice that also
carried the HoxB7-Cre transgene. Offspring were analyzed at
various stages, from E11.5 to weaning.
At E11.5, the ureteric bud has invaded the metanephric
mesenchyme and branched into a T-shaped structure. No
significant differences were observed in PTEN− kidneys at that
time. To examine the pattern of branching morphogenesis, we
cultured kidneys in serum free media for 48 h on transwell
filters. The branching pattern was examined by staining with
anti-laminin and anti-cytokeratins (Fig. 5). PTEN− kidneys
showed subtle alterations in branching patterns, particularly atthe tips. While PTEN+ ureteric bud tips were generally
rounded, symmetrical and covered by a smooth laminin
containing basement membrane, PTEN− ureteric bud tips
were often dilated, asymmetric and exhibited discontinuous and
gnarly basement membranes. In PTEN− kidneys, the ureteric
bud stalks showed increased kinks and small ectopic bud
outgrowths. Condensation of the mesenchyme was not grossly
affected, neither was glomerulogenesis.
At the newborn stage, we examined the pattern of
branching morphogenesis kidneys by immunostaining with
anti-cytokeratins which are specific for the ureteric bud
derived epithelia (Figs. 6A–D). The PTEN− kidneys had
terminal end buds that were often dilated and connected to
misshaped stalks. PTEN+ end buds did not exhibit these
dilations and the stalks were generally straight along the radial
axis of the kidney. We also examined older mice at 14 and 20
days post-partum. At 14 days, the density of glomeruli within
the outermost cortical layer was significantly increased, from
6.4±1.9 to 10.7±2.5 per unit area (Fig. 7A). Some glomeruli
in the PTEN− mice sat directly under the capsule (Fig. 6F),
something that is never seen in a wild-type kidney. By 14
days, significant glomerular pathology was evident. Most
glomeruli in PTEN− mice were small, with little evidence of
capillary blood flow and still unevenly positioned within the
cortex (Figs. 6E–H).
None of the ptenL/L;HoxB7-Cre mice (PTEN−) survived
more than 26 days postnatally (Fig. 7B). These PTEN− mice
were easily phenotyped by 2 weeks due to smaller body size and
sickly appearance. To confirm a reduction in PTEN protein
Fig. 5. In vitro branching morphogenesis of PTEN:HoxB7Cre kidney rudiments. E11.5 kidneys were cultured for 48 h in serum free media and stained for cytokeratin
(green) and laminin (red). (A–C) Three different PTEN− kidney rudiments showing subtle branching defects. Note the asymmetric end buds (A, arrows), the
abnormally large misshapen ampullae (B, arrows) and ectopic minor branches (C, arrow). The ureteric bud stalks are excessively kinked. (D–E) Control kidney
rudiments lacking the Cre transgene. The PTEN genotype is indicated. (G) A typical wild-type terminal end bud is smooth and covered by a continuous basement
membrane, with rounded termini (arrows). (H) A typical PTEN− ureteric bud lacks the smooth appearance of the wild-types. The termini show an enlarged ampullae
with rough edges and jagged basement membrane that can be discontinuous (arrows).
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lysates was done. In the newborns, the levels of PTEN protein in
the HoxB7Cre mice were reduced by 30% when compared to
total Akt, or 50% when compared to E-cadherin (Fig. 7C). The
remaining PTEN protein levels in the PTEN− mice are likely
due to the cell types not expressing HoxB7Cre, such as
endothelial cells, glomeruli and more proximal tubule cells. To
better visualize the loss of PTEN, immunohistochemistry was
performed on paraffin sections from 14-day-old littermates (Fig.
8). Diffuse cytoplasmic and nuclear staining is seen in most
cells from a PTEN+ kidney, whereas PTEN− sections show
epithelial structures with no PTEN staining (Figs. 8A, C).
Particularly the epithelial cells surrounding small, subcapsular
cyst shows complete lack of PTEN protein. These cysts are
DBA lectin positive epithelia, consistent with their derivation
from the ureteric buds (Figs. 8B, D).
These data demonstrate that subtle branching defects, which
begin early in development, can lead to significant patterning
defects within the branching collecting duct system and the
nephrons that are induced by these branching tips.Discussion
In this report, we provide evidence that the PI3K and the
PTEN phosphatase drive RET mediated chemotaxis in renal
epithelial cells. Several previous reports suggest PI3K as a
downstream effector of RET signaling in both renal and neural
cell chemotaxis (Natarajan et al., 2002; Srinivasan et al., 2005;
Tang et al., 2002). However, these studies relied solely on
pharmacological inhibitors whose specificity may be concen-
tration dependent and not complete. That PI3K responds to
GDNF in Ret9 cells is illustrated by the asymmetrical
localization of Akt-GFP fusion proteins to the leading edges
of migrating cells, closest to the source of GDNF. In fact,
lamellipodia could be discerned that showed multiple exten-
sions at the tips, whereby only the tips growing towards GDNF
showed strong PI3K activation. The data suggest that RET
activation responds to positional cues and can interpret a GDNF
gradient such that cells move towards the source. Ret mediated
chemotaxis can be suppressed by overexpressing the phospha-
tase PTEN, further supporting an essential role for PI(3,4,5)P3.
Fig. 6. Patterning defects in PTEN:HoxB7Cre kidneys. (A–D) Newborn kidney sections were stained for ureteric bud derivatives with anti-cytokeratin; genotypes are
as indicated. Note the enlarged lumen in PTEN− ureteric bud tips (arrows) and the kinked collecting ducts (arrowhead). (E–H) 14-day-old kidneys were embedded in
paraffin, sectioned and stained with Periodic Acid Shiff. PTEN− kidneys show unusual subcapsular glomeruli (arrow, F). Also, note high density of cortical glomeruli
in PTEN− kidneys. Boxes in G and H represent areas counted for quantitation as shown in Fig. 7.
Fig. 7. Quantitative analysis of PTEN:HoxB7Cre kidneys. (A) Peripheral glomeruli were counted in sections from 14-day-old kidneys within a fixed area (0.25 mm2)
at a range from 0 to 0.4 mm from the capsule. More than 100 data points were collected from 5 different kidneys for each genotype. Results are presented as the mean
with one standard deviation (pb0.01). (B) Survival curve of PTEN+ and PTEN− (n=14) animals. (C) Levels of PTEN protein were measured byWestern blot analysis
and normalized to either Akt or E-cadherin levels using fluorescent conjugated secondary antibodies and a Li-Cor Odyssey infrared imager. Mean protein ratios from 3
separate kidneys are shown with error bars being one standard deviation from the mean (pb0.02).
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Fig. 8. Localization of PTEN in 14-day postnatal kidneys. (A) Cortex of PTEN+ kidney stained with rabbit anti-PTEN and immunoperoxidase conjugated secondary
antibodies shows diffuse cytoplasmic and nuclear staining throughout cortex. (B) Collecting tubules (red) of PTEN+ section. Nuclei are stained with DAPI (blue). (C)
PTEN− cortex shows fewer PTEN positive cells, particularly within the microcystic epithelia of the collecting tubules (arrows). (D) DBA (red) staining of collecting
tubules within the cortex or PTEN− kidneys again shows higher density and cystic morphology.
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be modeled as a chemotactic driven process at the whole tissue
level. In isolated cells and model organisms such as Dictyos-
telium, the two principle events leading to cell migration are
polymerization of filamentous F-actin followed by protrusion
of cell surface at the leading edge and assembly of myosin II
resulting in contraction at the posterior (Levi et al., 2002).
Binding of chemoattractant ligands to receptors at the leading
edge activates PI3K and produces local spikes of high PI(3,4,5)
P3 concentrations (Arrieumerlou and Meyer, 2005). These
local spikes, within the context of an already polarized cell, can
lead to small changes in directional turning of lamellipodia and
directed migration towards high concentrations of ligand
(Arrieumerlou and Meyer, 2005). Binding of the PH domain
protein Akt/PKB to PI(3,4,5)P3 results in asymmetric signaling
responses that drive the chemotactic process (Meili et al.,
1999). In our cell system, Akt-GFP fusion protein localization
to lamellipodia closest to the source of GDNF also indicates
asymmetric activation of RET and subsequent activation of
PI3K. Cells transfected with Akt-GFP showed varying
amounts of fluorescence. Many cells had high nuclear and
perinuclear fluorescence, yet GFP at the cell surface was
generally low. Diffusion of GDNF from beads embedded inthin collagen gels presumably generates a gradient within the
gel that can be sensed by cells migrating on top of the gel.
These cells showed GFP expression on the cell surface, with
enhanced levels on the leading edges of lamellipodia and
membrane ruffles closest to the GDNF source. Even within a
bifurcated tip of a single lamellipodia, GFP localized to the
side closest to the source of GDNF. These data support a role
for RET in sensing local concentrations of GDNF as a
prerequisite for directional migration.
Concurrent with activation of PI3K at the leading edges close
to the chemoattractant source, the opposing sides of a migrating
cell can show high PTEN activity, which reduces the levels of PI
(3,4,5)P3, further polarizing the cell (Funamoto et al., 2002;
Iijima and Devreotes, 2002; Janetopoulos et al., 2004).
Reduction of PTEN gene dosage in B cells sensitizes cells to
cytokine mediated chemotaxis and Akt activation (Fox et al.,
2002), whereas complete PTEN deletion in mouse embryo
fibroblasts stimulates cell motility by activation of Rac and
cdc42 (Liliental et al., 2000). The deletion of the lipid
phosphatase Ship1 also results in chemotactic defects, primarily
in the homing of neutrophils to sites of inflammation (Nishio et
al., 2007). In our cell migration assays, expression of wild-type
PTEN inhibits migration to such an extent that chemotaxis can
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evidence that the PTEN-C124S mutant can act as a dominant
negative (Maehama and Dixon, 1998), which is consistent with
our observation that Ret9 cells expressing this mutant form
actually show a slight but statistically significant enhancement
of chemotaxis.
In the developing kidney, RET is expressed at the tips of the
ureteric bud and is essential for branching morphogenesis
(Schuchardt et al., 1996). The activity of RET is controlled at
multiple levels, by transcription factors that regulate receptor
and ligand expression (Brophy et al., 2001; Clarke et al., 2006;
Kume et al., 2000), by extracellular signaling factors such as
Robo/Slit (Grieshammer et al., 2004) and Bmp4 (Brophy et al.,
2001; Miyazaki et al., 2000) and by intracellular inhibitors of
tyrosine kinase activity such as Sprouty (Basson et al., 2005). If
PI3K activation and localized PI(3,4,5)P3 are important for
RET mediated branching morphogenesis, then deletion of
PTEN would increase PI(3,4,5)P3 throughout the cell, but
would not eliminate the ligand dependent activation of RET
nor the restricted expression pattern at the bud tips. Thus, the
PTEN− kidneys generated using the HoxB7Cre transgenic
driver are fundamentally different than several other mutants or
transgenic strains that deregulate RET activity. However, the
distorted ureteric bud tips are similar in morphology to those
observed with high doses of ectopic GDNF (Pepicelli et al.,
1997; Sainio et al., 1997) or expression of a constitutively
active form of RET in the ureteric bud epithelium (de Graaff et
al., 2001).
One revealing series of experiments by Shakya et al. (2005)
expressed GDNF using a HoxB7 transgene, essentially putting
the ligand and receptor within the same cell and crossing this
transgene into a GDNF null background. Thus, by eliminating
mesenchymal specific GDNF and replacing it with ureteric bud
expressed GDNF, many of the kidneys were still able to develop
with only minor defects. The authors conclude that mesench-
ymal GDNF is not required as a chemotactic signal. However in
those particular transgenic kidneys, the pattern of branching
morphogenesis could still be shaped by negative regulators of
RET activity that act both outside and within the ureteric bud
epithelia. That ectopic ureteric buds in HoxB7-GDNF trans-
genic embryos generally grew in the same direction may also
indicate that the surrounding mesenchymal environment is
conducive to invasion only along the dorso-lateral side or that
there are negative regulators of RET expressed medio-ventrally.
Similarly, in the PTEN− kidneys described here, many
additional negative regulators of RET, including Sprouty,
Bmp4 and Robo/Slit, are still acting on the epithelial cells.
The end result is in fact quite subtle and is probably best
observed within the early organ cultures at the bud tips. The
smooth, rounded ampullae are replaced by a dilated and rough
looking bud tip that in places shows discontinuity of the laminin
basement membrane. This translated to a patterning defect in
adult kidneys whereby glomeruli are not evenly distributed
within the cortex.
In summary, the data presented in this report indicate a role for
PI3K in RET mediated chemotaxis of renal epithelial cells.
Expression of the tumor suppressor PTEN can block the effectsof RET activation by counteracting the activation of PI3K to
inhibit cell migration. The mechanism of PTEN mediated
suppression of RET has implications for the development of
the collecting duct system as tissue specific PTEN knockouts
show subtle branching defects that result in mislocalization of
glomeruli and lethality. Furthermore, given the role of oncogenic
RET in tumor growth and invasion (Melillo et al., 2005), the
ability of PTEN to suppress this process also merits investigation.
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